Capitalization 2.69B 3.71B P/E ratio 2024 *
39.5x
P/E ratio 2025 * 29.3x
Enterprise value 3.47B 4.78B EV / Sales 2024 *
1.96x
EV / Sales 2025 * 1.53x
Free-Float
85.53%
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.57%
1 week-4.87%
Current month-1.64%
1 month+7.73%
3 months-13.68%
6 months-26.43%
Current year-24.31%
More quotes
1 week
27.05
Extreme 27.05
29.78
1 month
25.69
Extreme 25.69
30.42
Current year
23.90
Extreme 23.9
42.08
1 year
23.90
Extreme 23.9
44.95
3 years
23.90
Extreme 23.9
68.32
5 years
13.29
Extreme 13.29
68.32
10 years
13.29
Extreme 13.29
68.32
More quotes
Insider TitleAgeSince
Chief Executive Officer 56 16-12-31
President 47 21-02-28
Director of Finance/CFO 58 19-04-30
Insider TitleAgeSince
Director/Board Member 67 10-04-30
Director/Board Member 67 15-02-28
Chairman 64 16-12-15
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-0.57%-4.87%-28.25%-48.38% 2.69B
+0.62%-2.70%+9.65%+34.88% 511B
+0.65%-2.13%+15.53%+47.71% 95.5B
+0.03%-4.15%-14.99%-17.51% 46.5B
+0.98%-3.38%-7.55%-9.85% 34.63B
+0.05%-3.30%-8.18%+11.81% 16.81B
-1.31%-6.50%+51.29%-52.44% 1.82B
+0.30%-2.07%+50.39%-79.46% 824M
Average +0.11%-3.55%+8.49%-14.15% 88.66B
Weighted average by Cap. +0.61%-0.03%+7.58%+29.77%
See all sector performances
Ratios2024 *2025 *
Net sales 1.23B 1.7B 1.45B 1.99B
Net income 73.84M 102M 96.57M 133M
Net Debt -269M -370M -480M -661M
More financial data * Estimated data
Logo Progyny, Inc.
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.4 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.
Employees
565
Calendar
Related indices
More about the company
Date Price Change Volume
24-07-24 28.12 $ -0.51% 102 417
24-07-23 28.26 $ +3.06% 674,625
24-07-22 27.42 $ -1.33% 1,117,597
24-07-19 27.79 $ -0.82% 1,167,956
24-07-18 28.02 $ -5.27% 978,796

Delayed Quote Nasdaq, July 24, 2024 at 11:49 am

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
28.26USD
Average target price
37.80USD
Spread / Average Target
+33.76%
Consensus